AERAMI THERAPEUTICS HOLDINGS, INC.

Profile

Company Names

AERAMI THERAPEUTICS HOLDINGS, INC.
DANCE BIOPHARM HOLDINGS, INC.

Addresses

600 PARK OFFICES DR., STE. 300, DURHAM, NC 27709

500 LAKE COOK ROAD, SUITE 350, DEERFIELD, IL 60015

2520 MERIDIAN PARKWAY, SUITE 400, DURHAM, NC 27713

2 MINT PLAZA, SUITE 804, SAN FRANCISCO, CA 94103

150 NORTH HILL DRIVE, SUITE 24, BRISBANE, CA 94005

Phone Numbers

919-797-9792
9195897495
415-369-9415

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$87,517,456.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2023-11-09 
$1,016,000.00 
$20,000,000.00 
$18,984,000.00 
Debt 
8
2022-10-31 
$5,380,000.00 
$20,000,000.00 
$14,620,000.00 
Equity 
7
2021-09-17 
$22,250,560.00 
$22,250,560.00 
$0.00 
Equity 
6
2020-06-05 
$4,608,000.00 
$15,000,000.00 
$10,392,000.00 
Equity 
5
2019-01-07 
$21,046,000.00 
$59,200,000.00 
$38,154,000.00 
Equity 
4
2017-11-30 
$19,033,459.00 
$36,699,455.00 
$17,665,996.00 
Equity 
3
2017-04-07 
$3,424,404.00 
$5,000,000.00 
$1,575,596.00 
Equity 
2
2016-06-20 
$625,000.00 
$23,000,000.00 
$22,375,000.00 
Equity 
1
2015-09-30 
$10,134,033.00 
$40,000,000.00 
$29,865,967.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
BELL 
EXECUTIVE OFFICER
GARY 
C. 
BURGESS 
EXECUTIVE OFFICER
AUGUSTINE 
P.Y. 
CHOW, M.D. 
DIRECTOR
TIMM 
 
CROWDER 
EXECUTIVE OFFICER
DARLENE 
 
DEPTULA-HICKS 
DIRECTOR, EXECUTIVE OFFICER
BARRY 
 
DEUTSCH 
EXECUTIVE OFFICER
DONALD 
D. 
HUFFMAN 
DIRECTOR, EXECUTIVE OFFICER
MICHAEL 
J. 
KASETA 
EXECUTIVE OFFICER
MIKE 
 
KASETA 
EXECUTIVE OFFICER
KENNETH 
B. 
LEE, JR. 
DIRECTOR
TYLER 
 
MARTIN, M.D. 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
S. 
PATTON 
DIRECTOR
JOHN 
S. 
PATTON, PH.D 
EXECUTIVE OFFICER, DIRECTOR
LISA 
E. 
PORTER, M.D. 
EXECUTIVE OFFICER
DR. MELISSA 
 
RHODES 
EXECUTIVE OFFICER
ADAM 
 
STERN 
DIRECTOR
PROLOR BIOTECH, INC.   |  LABSTYLE INNOVATIONS CORP.   |  MATINAS BIOPHARMA HOLDINGS, INC.   |  TCG PRIVATE SELECT PARTNERS, L.P.   |  DANCE BIOPHARM INC.   |  360 ENERGY OPPORTUNITY FUND, LP   |  ELEVEN JAMES, INC.   |  DANCE BIOPHARM HOLDINGS, INC.   |  ATLAS ENHANCED ACCESS FUND LP   |  GC OPPORTUNITIES I PRIVATE FUND, LP   |  FUNDAMENTAL PARTNERS III ACCESS FUND LP   |  TCG PRIVATE SELECT PARTNERS II, L.P.   |  CCA PINECREST INVESTORS, LP   |  COBBLESTONE PRIVATE REAL ESTATE FUND, LP   |  REAL ESTATE SENIOR LOAN ACCESS FUND, LP   |  PEAK MULTIFAMILY I ACCESS FUND, LP   |  LGA INCOME PLUS FUND, LP   |  GC OPPORTUNITIES 2 PRIVATE FUND LP   |  HCA SPECIAL OPPORTUNITIES FUND, LP   |  HCA GLOBAL ALPHA FUND LP   |  HCA GLOBAL ALPHA FUND OFFSHORE LTD   |  COBBLESTONE PRIVATE CREDIT FUND, LP   |  EMPIRICAL ALTERNATIVE INCOME FUND, LP   |  ALIGN IMPACT FUND II, LP   |  HCA WINDACRE ACCESS FUND, LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA I   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES PLANT PROTEIN I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES PLANT PROTEIN I   |  HYDROFARM HOLDINGS GROUP, INC.   |  SHOREPOINT INCOME FUND I LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES HOSPITALITY I   |  TCG PRIVATE SELECT PARTNERS III LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FANTASY SPORTS I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH I   |  AERAMI THERAPEUTICS HOLDINGS, INC.   |  DARIOHEALTH CORP.   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES DIGITAL FREIGHT NETWORK I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AGRITECH II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FINTECH I   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES AGRITECH II   |  SPRING TARGETED OPPORTUNITY III LLC   |  AGRITECH QP PARTNERS LLC - SERIES HB-1   |  AGRITECH PARTNERS LLC - SERIES HB-1   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE II   |  SPRING TARGETED OPPORTUNITY IV LLC   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH V   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES HEALTHTECH I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VI   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VI   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FINTECH III   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VIII   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VIII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IX   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH X   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XI   |  PURSUIT FUND ADVISERS LLC   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES DAS I
STEVE 
 
THORNTON 
DIRECTOR, EXECUTIVE OFFICER
STEVEN 
 
THORNTON 
DIRECTOR, EXECUTIVE OFFICER
BILL 
 
WELCH 
DIRECTOR
WILLIAM 
PATRICK 
WELCH 
DIRECTOR
ANNE 
 
WHITAKER 
EXECUTIVE OFFICER, DIRECTOR
ANNE 
C. 
WHITAKER 
EXECUTIVE OFFICER, DIRECTOR
BEN 
 
WOLIN 
DIRECTOR
VIVIAN 
 
YAN 
DIRECTOR
LISA 
 
YANEZ 
EXECUTIVE OFFICER
GREG 
S. 
ZANTE 
EXECUTIVE OFFICER
JOSHUA 
 
ZIEL 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2023-11-09 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-31 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-17 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-17 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-05 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AEGIS CAPITAL CORP.
NONE
NONE
AEGIS CAPITAL CORP.
NONE
NONE
AEGIS CAPITAL CORP.
NONE
NONE
AEGIS CAPITAL CORP
NONE
NONE
FINANCIAL WEST GROUP, INC.